LOW-VOLUME · HOSP-HEAVY
atomoxetine Side Effects
atomoxetine (also sold as Strattera) is a LOW-VOLUME FAERS extract #425 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 37.3% mention hospitalization (1,203 reports).
Data updated 2026-05-15
- 3,228
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
atomoxetine: 37.3% mention hospitalization (1,203 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #425 of 524 by FAERS report count.
Thinner FAERS extract for atomoxetine (Strattera) (3,228 reports #425 of 524 by FAERS report count). 37.3% mention hospitalization (1,203 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 431 of 3,228 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (1,400 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (879 reports, 27.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| ARTHRALGIA | 327 |
| GLOSSODYNIA | 325 |
| HYPERTENSION | 325 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 324 |
| HEPATIC ENZYME INCREASED | 324 |
| ABDOMINAL DISCOMFORT | 319 |
| ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE | 317 |
| BLOOD CHOLESTEROL INCREASED | 317 |
| ALOPECIA | 314 |
| ARTHROPATHY | 314 |
| HAND DEFORMITY | 313 |
| JOINT SWELLING | 312 |
| NAIL DISORDER | 308 |
| CONDITION AGGRAVATED | 293 |
| MATERNAL EXPOSURE DURING PREGNANCY | 290 |
| NAUSEA | 271 |
| PEMPHIGUS | 271 |
| INFUSION RELATED REACTION | 270 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,203, 37.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| CONDITION AGGRAVATED | 317 |
| HYPERTENSION | 311 |
| HEPATIC ENZYME INCREASED | 308 |
| HEADACHE | 303 |
| ARTHRALGIA | 300 |
| BLOOD CHOLESTEROL INCREASED | 299 |
| ABDOMINAL DISCOMFORT | 298 |
| ALOPECIA | 295 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 295 |
| GLOSSODYNIA | 294 |
| ARTHROPATHY | 293 |
| FATIGUE | 293 |
| INSOMNIA | 293 |
| JOINT SWELLING | 293 |
| GASTROINTESTINAL DISORDER | 292 |
| HAND DEFORMITY | 292 |
| ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE | 288 |
How to read atomoxetine FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 3,228 voluntary reports linked to atomoxetine (Strattera), 2004-2025. Death is listed on 879 (27.2%). Hospitalization appears on 1,203 (37.3%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with atomoxetine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 3,219 FAERS cases (Δ 9 lighter vs atomoxetine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,245 FAERS cases (Δ 17 heavier vs atomoxetine); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,267 FAERS cases (Δ 39 heavier vs atomoxetine); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,268 FAERS cases (Δ 40 heavier vs atomoxetine); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 34.9 pp vs atomoxetine's DEATH-HEAVY): CASELOAD · HOSP-MID.
atomoxetine stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.